EG

Ehiteshamuddin Giyasuddin Shaikh

Active Director Director DIN 09431491
DIN 09431491 First appointment Dec 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Ehiteshamuddin Giyasuddin Shaikh

Data last updated:

Ehiteshamuddin Giyasuddin Shaikh is a Director at Axohealth Private Limited (since 2021). The company operates in Chemicals.

DIN 09431491
Primary Designation Director
Industry Chemicals
First Appointment 10 Dec 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Axohealth Private Limited U24119PN2021PTC206823
Director10 Dec 20212021Active

Board colleagues of Ehiteshamuddin Giyasuddin Shaikh

NameDINCompanyDesignation
Syed Arshadali Hashmi09420153Axohealth Private LimitedDirector

Directorship timeline

Open interactive timeline →
Axohealth Private Limited
Premium access

Shareholding and investment profile for Ehiteshamuddin Giyasuddin Shaikh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ehiteshamuddin Giyasuddin Shaikh

Ehiteshamuddin Giyasuddin Shaikh currently holds 1 directorship: Axohealth Private Limited (Director, since 10 Dec 2021).

Ehiteshamuddin Giyasuddin Shaikh was first appointed on 10 Dec 2021 as Director at Axohealth Private Limited.

The current boards of Ehiteshamuddin Giyasuddin Shaikh's companies include Syed Arshadali Hashmi (Axohealth Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available